1. Machine learning-based 28-day mortality prediction model for elderly neurocritically Ill patients.
- Author
-
Yuan J, Xiong J, Yang J, Dong Q, Wang Y, Cheng Y, Chen X, Liu Y, Xiao C, Tao J, Lizhang S, Liujiao Y, Chen Q, and Shen F
- Subjects
- Humans, Aged, Female, Male, Intensive Care Units, Prognosis, Aged, 80 and over, Algorithms, Kaplan-Meier Estimate, Databases, Factual, Machine Learning, Critical Illness mortality
- Abstract
Background: The growing population of elderly neurocritically ill patients highlights the need for effective prognosis prediction tools. This study aims to develop and validate machine learning (ML) models for predicting 28-day mortality in intensive care units (ICUs)., Methods: Data were extracted from the Medical Information Mart for Intensive Care IV(MIMIC-IV) database, focusing on elderly neurocritical ill patients with ICU stays ≥ 24 h. The cohort was split into 70 % for training and 30 % for internal validation. We analyzed 58 variables, including demographics, vital signs, medications, lab results, comorbidities, and medical scores, using Lasso regression to identify predictors of 28-day mortality. Seven ML algorithms were evaluated, and the best model was validated with data from Guizhou Medical University Affiliated Hospital. A log-rank test was used to assess survival differences in Kaplan-Meier curves. Shapley Additive Explanations (SHAP) were used to interpret the best model, while subgroup analysis identified variations in model performance across different populations., Results: The study included 1,773 elderly neurocritically ill patients, with a 28-day mortality rate of 28.6 %. The Light Gradient Boosting Machine (LightGBM) outperformed other models, achieving an area under the curve (AUC) of 0.896 in internal validation and 0.812 in external validation. Kaplan-Meier analysis showed that higher LightGBM prediction scores correlated with lower survival probabilities. Key predictors identified through SHAP analysis included partial pressure of arterial carbon dioxide (PaCO
2 ), Acute physiology and chronic health evaluation II (APACHE II), white blood cell count, age, and lactate. The LightGBM model demonstrated consistent performance across various subgroups., Conclusions: The LightGBM model effectively predicts 28-day mortality risk in elderly neurocritically ill patients, aiding clinicians in management and resource allocation. Its reliable performance across diverse subgroups underscores its clinical utility., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.)- Published
- 2025
- Full Text
- View/download PDF